Personal information

No personal information available

Activities

Collapse all

Works (17)

Data from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.c.7403529.v1
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Data from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.c.7403529
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

Clinical Cancer Research
2024-08-15 | Journal article
DOI: 10.1158/1078-0432.CCR-23-3157
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.26711208
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.26711208.v1
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.26711205
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.26711205.v1
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.26711199.v1
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.26711199
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.26711196
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.26711196.v1
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.26711190
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.26711190.v1
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Supplementary Methods S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.26711187.v1
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Supplementary Methods S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.26711187
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Supplementary Table S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.26711184.v1
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref

Supplementary Table S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

2024-08-15 | Preprint
DOI: 10.1158/1078-0432.26711184
Contributors: Lena Fischer-Riepe; Sareetha Kailayangiri; Katharina Zimmermann; Rita Pfeifer; Michael Aigner; Bianca Altvater; Sascha Kretschmann; Simon Völkl; Jordan Hartley; Celine Dreger et al.
Source: check_circle
Crossref
How many people are using ORCID?